Hemostasis Diagnostic Device Market Size(US$)

CAGR 2025-2031
7.2%
Market Size,2031
USD 1,886
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemostasis Diagnostic Device was valued at US$ 1167 million in the year 2024 and is projected to reach a revised size of US$ 1886 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hemostasis Diagnostic Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis Diagnostic Device.
The Hemostasis Diagnostic Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostasis Diagnostic Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostasis Diagnostic Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
Baxter
Johnson and Johnson
Abbott Laboratories
Beckman Coulter
Roche
Integra Life Sciences
Medtronic
Siemens
Thermo Fisher Scientific
Boston Scientific
Olympus
Cook Medical
Halyard
Pentax
ConMed
Fujinon
Moog
Segment by Type
Analyzers
Coagulation Instrument
Others
Segment by Application
Hospitals
Clinics
Independent Diagnostic
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostasis Diagnostic Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostasis Diagnostic Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hemostasis Diagnostic Device Market Overview
1.1 Product Definition
1.2 Hemostasis Diagnostic Device by Type
1.2.1 Global Hemostasis Diagnostic Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Analyzers
1.2.3 Coagulation Instrument
1.2.4 Others
1.3 Hemostasis Diagnostic Device by Application
1.3.1 Global Hemostasis Diagnostic Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Diagnostic
1.3.5 Others
1.4 Global Hemostasis Diagnostic Device Market Size Estimates and Forecasts
1.4.1 Global Hemostasis Diagnostic Device Revenue 2020-2031
1.4.2 Global Hemostasis Diagnostic Device Sales 2020-2031
1.4.3 Global Hemostasis Diagnostic Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemostasis Diagnostic Device Market Competition by Manufacturers
2.1 Global Hemostasis Diagnostic Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemostasis Diagnostic Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemostasis Diagnostic Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemostasis Diagnostic Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostasis Diagnostic Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostasis Diagnostic Device, Product Type & Application
2.7 Global Key Manufacturers of Hemostasis Diagnostic Device, Date of Enter into This Industry
2.8 Global Hemostasis Diagnostic Device Market Competitive Situation and Trends
2.8.1 Global Hemostasis Diagnostic Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemostasis Diagnostic Device Players Market Share by Revenue
2.8.3 Global Hemostasis Diagnostic Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostasis Diagnostic Device Market Scenario by Region
3.1 Global Hemostasis Diagnostic Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemostasis Diagnostic Device Sales by Region: 2020-2031
3.2.1 Global Hemostasis Diagnostic Device Sales by Region: 2020-2025
3.2.2 Global Hemostasis Diagnostic Device Sales by Region: 2026-2031
3.3 Global Hemostasis Diagnostic Device Revenue by Region: 2020-2031
3.3.1 Global Hemostasis Diagnostic Device Revenue by Region: 2020-2025
3.3.2 Global Hemostasis Diagnostic Device Revenue by Region: 2026-2031
3.4 North America Hemostasis Diagnostic Device Market Facts & Figures by Country
3.4.1 North America Hemostasis Diagnostic Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemostasis Diagnostic Device Sales by Country (2020-2031)
3.4.3 North America Hemostasis Diagnostic Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostasis Diagnostic Device Market Facts & Figures by Country
3.5.1 Europe Hemostasis Diagnostic Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemostasis Diagnostic Device Sales by Country (2020-2031)
3.5.3 Europe Hemostasis Diagnostic Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostasis Diagnostic Device Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostasis Diagnostic Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemostasis Diagnostic Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemostasis Diagnostic Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostasis Diagnostic Device Market Facts & Figures by Country
3.7.1 Latin America Hemostasis Diagnostic Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemostasis Diagnostic Device Sales by Country (2020-2031)
3.7.3 Latin America Hemostasis Diagnostic Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostasis Diagnostic Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostasis Diagnostic Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemostasis Diagnostic Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemostasis Diagnostic Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostasis Diagnostic Device Sales by Type (2020-2031)
4.1.1 Global Hemostasis Diagnostic Device Sales by Type (2020-2025)
4.1.2 Global Hemostasis Diagnostic Device Sales by Type (2026-2031)
4.1.3 Global Hemostasis Diagnostic Device Sales Market Share by Type (2020-2031)
4.2 Global Hemostasis Diagnostic Device Revenue by Type (2020-2031)
4.2.1 Global Hemostasis Diagnostic Device Revenue by Type (2020-2025)
4.2.2 Global Hemostasis Diagnostic Device Revenue by Type (2026-2031)
4.2.3 Global Hemostasis Diagnostic Device Revenue Market Share by Type (2020-2031)
4.3 Global Hemostasis Diagnostic Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemostasis Diagnostic Device Sales by Application (2020-2031)
5.1.1 Global Hemostasis Diagnostic Device Sales by Application (2020-2025)
5.1.2 Global Hemostasis Diagnostic Device Sales by Application (2026-2031)
5.1.3 Global Hemostasis Diagnostic Device Sales Market Share by Application (2020-2031)
5.2 Global Hemostasis Diagnostic Device Revenue by Application (2020-2031)
5.2.1 Global Hemostasis Diagnostic Device Revenue by Application (2020-2025)
5.2.2 Global Hemostasis Diagnostic Device Revenue by Application (2026-2031)
5.2.3 Global Hemostasis Diagnostic Device Revenue Market Share by Application (2020-2031)
5.3 Global Hemostasis Diagnostic Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Hemostasis Diagnostic Device Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Hemostasis Diagnostic Device Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Hemostasis Diagnostic Device Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Company Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Laboratories Hemostasis Diagnostic Device Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Beckman Coulter
6.5.1 Beckman Coulter Company Information
6.5.2 Beckman Coulter Description and Business Overview
6.5.3 Beckman Coulter Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beckman Coulter Hemostasis Diagnostic Device Product Portfolio
6.5.5 Beckman Coulter Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Hemostasis Diagnostic Device Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Integra Life Sciences
6.7.1 Integra Life Sciences Company Information
6.7.2 Integra Life Sciences Description and Business Overview
6.7.3 Integra Life Sciences Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Integra Life Sciences Hemostasis Diagnostic Device Product Portfolio
6.7.5 Integra Life Sciences Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Company Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Medtronic Hemostasis Diagnostic Device Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Siemens
6.9.1 Siemens Company Information
6.9.2 Siemens Description and Business Overview
6.9.3 Siemens Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Siemens Hemostasis Diagnostic Device Product Portfolio
6.9.5 Siemens Recent Developments/Updates
6.10 Thermo Fisher Scientific
6.10.1 Thermo Fisher Scientific Company Information
6.10.2 Thermo Fisher Scientific Description and Business Overview
6.10.3 Thermo Fisher Scientific Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Thermo Fisher Scientific Hemostasis Diagnostic Device Product Portfolio
6.10.5 Thermo Fisher Scientific Recent Developments/Updates
6.11 Boston Scientific
6.11.1 Boston Scientific Company Information
6.11.2 Boston Scientific Description and Business Overview
6.11.3 Boston Scientific Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boston Scientific Hemostasis Diagnostic Device Product Portfolio
6.11.5 Boston Scientific Recent Developments/Updates
6.12 Olympus
6.12.1 Olympus Company Information
6.12.2 Olympus Description and Business Overview
6.12.3 Olympus Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Olympus Hemostasis Diagnostic Device Product Portfolio
6.12.5 Olympus Recent Developments/Updates
6.13 Cook Medical
6.13.1 Cook Medical Company Information
6.13.2 Cook Medical Description and Business Overview
6.13.3 Cook Medical Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cook Medical Hemostasis Diagnostic Device Product Portfolio
6.13.5 Cook Medical Recent Developments/Updates
6.14 Halyard
6.14.1 Halyard Company Information
6.14.2 Halyard Description and Business Overview
6.14.3 Halyard Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Halyard Hemostasis Diagnostic Device Product Portfolio
6.14.5 Halyard Recent Developments/Updates
6.15 Pentax
6.15.1 Pentax Company Information
6.15.2 Pentax Description and Business Overview
6.15.3 Pentax Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Pentax Hemostasis Diagnostic Device Product Portfolio
6.15.5 Pentax Recent Developments/Updates
6.16 ConMed
6.16.1 ConMed Company Information
6.16.2 ConMed Description and Business Overview
6.16.3 ConMed Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.16.4 ConMed Hemostasis Diagnostic Device Product Portfolio
6.16.5 ConMed Recent Developments/Updates
6.17 Fujinon
6.17.1 Fujinon Company Information
6.17.2 Fujinon Description and Business Overview
6.17.3 Fujinon Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Fujinon Hemostasis Diagnostic Device Product Portfolio
6.17.5 Fujinon Recent Developments/Updates
6.18 Moog
6.18.1 Moog Company Information
6.18.2 Moog Description and Business Overview
6.18.3 Moog Hemostasis Diagnostic Device Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Moog Hemostasis Diagnostic Device Product Portfolio
6.18.5 Moog Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostasis Diagnostic Device Industry Chain Analysis
7.2 Hemostasis Diagnostic Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostasis Diagnostic Device Production Mode & Process Analysis
7.4 Hemostasis Diagnostic Device Sales and Marketing
7.4.1 Hemostasis Diagnostic Device Sales Channels
7.4.2 Hemostasis Diagnostic Device Distributors
7.5 Hemostasis Diagnostic Device Customer Analysis
8 Hemostasis Diagnostic Device Market Dynamics
8.1 Hemostasis Diagnostic Device Industry Trends
8.2 Hemostasis Diagnostic Device Market Drivers
8.3 Hemostasis Diagnostic Device Market Challenges
8.4 Hemostasis Diagnostic Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published Date: 2024-01-17
Pages: 102
USD 2900.00
(Single User License)
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published Date: 2024-04-12
Pages: 114
USD 4900.00
(Single User License)
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published Date: 2024-01-10
Pages: 137
USD 3950.00
(Single User License)
The global market for Hemostasis Diagnostic Device was estimated to be worth US$ 1167 million in 2024 and is forecast to a readjusted size of US$ 1886 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 139
USD 3950.00
(Single User License)
The global Hemostasis Diagnostic Device market is projected to grow from US$ 1167 million in 2024 to US$ 1886 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global Hemostasis Diagnostic Device market size was US$ 1167 million in 2024 and is forecast to a readjusted size of US$ 1886 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 104
USD 4250.00
(Single User License)
The global Hemostasis Diagnostic Device market was valued at US$ 1243 million in 2025 and is anticipated to reach US$ 2008 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 136
USD 2900.00
(Single User License)
The global market for Hemostasis Diagnostic Device was estimated to be worth US$ 1243 million in 2025 and is projected to reach US$ 2008 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 152
USD 3950.00
(Single User License)
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published: 2024-01-17
Pages: 102
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published: 2024-04-12
Pages: 114
Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.
Published: 2024-01-10
Pages: 137
The global market for Hemostasis Diagnostic Device was estimated to be worth US$ 1167 million in 2024 and is forecast to a readjusted size of US$ 1886 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 139
The global Hemostasis Diagnostic Device market is projected to grow from US$ 1167 million in 2024 to US$ 1886 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global Hemostasis Diagnostic Device market size was US$ 1167 million in 2024 and is forecast to a readjusted size of US$ 1886 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 104
The global Hemostasis Diagnostic Device market was valued at US$ 1243 million in 2025 and is anticipated to reach US$ 2008 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 136
The global market for Hemostasis Diagnostic Device was estimated to be worth US$ 1243 million in 2025 and is projected to reach US$ 2008 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 152
REPORT COVERAGE
DESCRIPTION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report